Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search

		Submit


Tuberculosis (TB)


Facebook
        Twitter
        LinkedIn
        Syndicate





Sharing Your TB Program Evaluation Findings										Related Pages
					Return to Main Menu***Disclaimer:***The activities in this tool are intended for example purposes only. The actual activities implemented as part of TB program evaluation should be identified by state or local TB program officials in collaboration with other partners. The activities in this tool are not intended to be applied directly to any specific TB program and are not a requirement of any DTBE-funded program. The external resources throughout this tool are informational and do not represent the official position of or endorsement by the U.S. Centers for Disease Control and Prevention.**This tool was developed to assist state and local tuberculosis (TB) prevention and control programs in sharing evaluation findings with various audiences.** It includes information on developing a communication strategy, visualizing data, ensuring the use of evaluation findings, and tips for using the National Tuberculosis Indicators Project (NTIP) performance reports. Definitions for key terms used in this tool can be found in the glossary of the CDC Introduction to Program Evaluation for Public Health Programs: A Self-Study Guide. The implementation of the activities and strategies mentioned in this tool are dependent on the availability of program resources and funds.On This Page
			Identifying AudiencesSharing Evaluation Findings with AudiencesData Visualization to Drive FindingsPromoting Use of Evaluation FindingsIdentifying Audiences(Adapted from CDC Division of Heart Disease and Stroke Prevention Evaluation Reporting, Defining Your AudienceCDC Division of Heart Disease and Stroke Prevention Evaluation Reporting, Defining Your Audience)
Identifying an audience is critical to effectively share and communicate evaluation findings. Consider who will be the audience receiving the information. For TB programs, these may include:
**Internal Audiences**
Internal audiences include individuals within a team, division, or program and leadership within an agency.
**Funders**Funders include organizations that fund a program’s work.
**People or Organizations with Interests in TB Prevention and Control**People or organizations that are invested in the program or interested in the results and recommendations of the evaluation can include, but are not limited to:
State TB Prevention and Control Program
County TB Prevention and Control Program
Local TB Clinics
Private providers caring for persons with TB
TB Centers of Excellence (COEs)
State/Local TB laboratories
Populations of focus for TB prevention and control
Indian Health Service and tribal organizations
Local hospitals for TB care and management
Regional and national TB controller associations
TB advisory councils
Refugee resettlement assistance agencies
Medical/nursing schools and related hospitals
Public health schools and associations
STD/HIV and viral hepatitis education, prevention and training centers
Health Resources and Services Administration (HRSA) primary care networks
Substance Abuse and Mental Health Services Administration (SAMHSA)
Bureau of Prisons
Homeless shelters and short-stay facilitiesSharing Evaluation Findings with AudiencesWhen sharing evaluation findings with an audience, it is important to address the audience’s specific needs and interests. Consider the audience’s needs and future uses of the evaluation’s findings in determining effective strategies for sharing the findings (adapted from Western Michigan Making Evaluation Meaningful Checklistexternal icon, CDC Developing an Effective Evaluation Report, and CDC Coffee Break: Strategies for Effective Reporting). Consider using the following questions as a guide for identifying audience interests when sharing evaluation findings:
**Why is this evaluation important to the audience?**
**What is critical for the audience to know, and with what level of detail?**
**What questions might the audience ask about the findings?**
**How might the audience interpret and use the evaluation findings?**Conveying your evaluation findings using effective communication and dissemination strategies (adapted from CDC Ensuring Use of Evaluation Findings Worksheet 6A) is another important aspect of sharing evaluation findings.
**Table 1: Guiding questions for identifying communication and dissemination methods for sharing evaluation findings**
Table 1: Guiding questions for identifying communication and dissemination methods for sharing evaluation findings
**Guiding Questions**
**Purpose****1.****What is the appropriate format to share the findings?**
Consider sharing your findings in a format preferred by the audience.
Format options include ***one-page or executive summaries, infographics, oral presentations, success stories, traditional evaluation reports, journal publications, dashboards, or a combination of formats***, and depend on the availability of program resources*.*
**Resources:**
Communication Table Plan: CDC Developing an Effective Evaluation Report
Customizable TB-specific Infographic: Customizable Take on TB Infographic with Instructions**2.****What dissemination method might be preferred by the audience?**
Choose a dissemination method that provides the best opportunity to reach the intended audience.
Different dissemination methods include ***emails, meetings (e.g. in-person or virtual), conferences, webinars, community forums, website postings, listservs, organizational newsletters, social media, or a combination of these.***
**Resources:**
CDC Coffee Break: Creating an Effective Dissemination PlanData Visualization to Drive FindingsData visualization is a powerful tool for examining and communicating evaluation data.
When sharing evaluation findings and data, the data should be clear, accessible, and interpretable in their visual presentations for the audience (adapted from CDC Coffee Break: The Power of Data Visualization and CDC Coffee Break: Strategies for Effective Reporting).
In general, effective data visualizations:
Tell a story about the data Are clear, simple, and easy to understand Support key messages Use color in a meaningful way
**Table 2: Considerations for developing impactful data visualizations when sharing evaluation findings**
Table 2: Considerations for developing impactful data visualizations when sharing evaluation findings
**Considerations**
**Visualization Options****Type of data (quantitative or qualitative) and the best way to represent the data visually**
Use ***graphs, tables, charts, or similar tools***to help the reader visualize ***quantitative***data.
Use***quotes,******word clouds******,******word trees***external icon***,******thematic networks******, or similar tools***to help the reader visualize ***qualitative*** data.
**Resources:**
Designing Effective Tables and Graphsexternal icon
CDC Coffee Break: Considerations for Presenting Qualitative Data**Color schemes and fonts for your organization**
Use ***consistent color schemes, fonts, and other stylistic elements***for your visualizations. Check with your organization to determine if they have developed a style guide.
**Resources:**
HHS Guidance and Checklists on 508 Complianceexternal icon**Appropriate visualizations for the format used**
****
Use visualizations that ***work well with the format*** in which the findings will be shared.
**Examples:**
Infographics might include the use of ***icons, descriptive statistics, bar charts, or maps*** on 1-2 pages.
Oral presentations might include the use of ***tables, bar charts, or quotes***on single slides.**Resources:**
Evaluation Report Layout Checklistexternal icon
Data Visualization Checklistexternal icon**Visualizing Your Data Using the National Tuberculosis Indicators Project (NTIP)**State and local TB programs can use NTIP, a web-based performance monitoring tool (NTIP Fact Sheet) to download already prepared images of their program’s performance compared to program objectives and national targets. The following examples show how NTIP images could be useful for sharing data.TB incidence rate for non-U.S.-born persons in the United States, 2015 to 2019TB incidence rate for non-U.S.-born persons in the United States, 2015 to 2019resize iconView Larger
CloseTB incidence rate for non-U.S.-born persons in the United States, 2015 to 2019TB incidence rate for non-U.S.-born persons in the United States, 2015 to 2019
download iconDownload Image[JPG]Examination status and reasons examination not completed for immigrants and refugees with abnormal chest x-rays read overseas as consistent with TB—United States, 2019Examination status and reasons examination not completed for immigrants and refugees with abnormal chest x-rays read overseas as consistent with TB—United States, 2019Note:“Completed examination” include records reported as having 1) completed examination, 2) treatment recommended (i.e. checked or reported as ‘Yes”), and 3) a ‘TB classification’ reported under Diagnosis. “Not located”, “died”, “moved within U.S.”, “returned to country of origin”, “lost to follow-up”, or “refused” include records reported as having ‘initiated evaluation/not completed’ or ‘did not initiate evaluation’. “Unknown/other” include records reported as 1) having ‘completed evaluation’, but missing data for Treatment Recommended or Diagnosis, or 2) having ‘initiated evaluation/not completed’ or ‘did not initiate evaluation’ and reason is recorded as “other or unknown”.
resize iconView Larger
CloseExamination status and reasons examination not completed for immigrants and refugees with abnormal chest x-rays read overseas as consistent with TB—United States, 2019Examination status and reasons examination not completed for immigrants and refugees with abnormal chest x-rays read overseas as consistent with TB—United States, 2019
Note:“Completed examination” include records reported as having 1) completed examination, 2) treatment recommended (i.e. checked or reported as ‘Yes”), and 3) a ‘TB classification’ reported under Diagnosis. “Not located”, “died”, “moved within U.S.”, “returned to country of origin”, “lost to follow-up”, or “refused” include records reported as having ‘initiated evaluation/not completed’ or ‘did not initiate evaluation’. “Unknown/other” include records reported as 1) having ‘completed evaluation’, but missing data for Treatment Recommended or Diagnosis, or 2) having ‘initiated evaluation/not completed’ or ‘did not initiate evaluation’ and reason is recorded as “other or unknown”.
download iconDownload Image[JPG]Examination and treatment disposition of immigrants and refugees in the United States—2019Examination and treatment disposition of immigrants and refugees in the United States—2019-resize iconView Larger
CloseExamination and treatment disposition of immigrants and refugees in the United States—2019Examination and treatment disposition of immigrants and refugees in the United States—2019-
download iconDownload Image[JPG]Promoting Use of Evaluation FindingsEvaluation findings are often used to determine the effectiveness of a program, identify areas for program improvement, and justify funding (adapted from Ensure Use of Evaluation Findings and Share Lessons Learned).
By tailoring how findings are shared, incorporating appropriate data visualizations, and promoting the use of evaluation findings, people and organizations with interest in TB prevention and control become empowered to apply the evaluation’s findings in ways that improve programs, reduce disease, and save lives.
With these uses in mind, it is important to recognize that sharing evaluation results is just one piece of the puzzle when working to promote the use of your findings. In addition to sharing evaluation findings, several other actions can help to promote their value and use. These include:
Engaging and involving people and organizations with interest in TB prevention and control throughout the evaluation.
Providing interim reports on findings.
Using findings to provide specific and actionable recommendations.
Using findings to promote and inform program improvements, such as developing and implementing a remediation plan.CDC Framework for Program Evaluation in Public HealthCDC Framework for Program Evaluation in Public Healthresize iconView Larger
CloseCDC Framework for Program Evaluation in Public HealthCDC Framework for Program Evaluation in Public Health
download iconDownload Image[GIF]
							
					
						Page last reviewed:  June 7, 2021										Content source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue